SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-14-002995
Filing Date
2014-09-17
Accepted
2014-09-17 13:13:36
Documents
19
Period of Report
2014-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm 8-K 17633
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 15430
3 GRAPHIC page1.jpg GRAPHIC 52059
4 GRAPHIC page2.jpg GRAPHIC 188081
5 GRAPHIC page3.jpg GRAPHIC 31195
6 GRAPHIC page4.jpg GRAPHIC 92861
7 GRAPHIC page5.jpg GRAPHIC 67536
8 GRAPHIC page6.jpg GRAPHIC 48404
9 GRAPHIC page7.jpg GRAPHIC 110292
10 GRAPHIC page8.jpg GRAPHIC 89487
11 GRAPHIC page9.jpg GRAPHIC 92333
12 GRAPHIC page10.jpg GRAPHIC 60440
13 GRAPHIC page11.jpg GRAPHIC 82819
14 GRAPHIC page12.jpg GRAPHIC 106533
15 GRAPHIC page13.jpg GRAPHIC 102693
16 GRAPHIC page14.jpg GRAPHIC 84764
17 GRAPHIC page15.jpg GRAPHIC 108175
18 GRAPHIC page16.jpg GRAPHIC 25391
19 GRAPHIC page17.jpg GRAPHIC 55742
  Complete submission text file 0001493152-14-002995.txt   1963922
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 141107343
SIC: 2834 Pharmaceutical Preparations